Tau Protein as a New Regulator of Cellular Prion Protein Transcription

[1]  A. McNeill.  A Molecular Analysis Of Prion Protein Expression In Alzheimer's Disease , 2020 .

[2]  I. Ferrer,et al.  The Quest for Cellular Prion Protein Functions in the Aged and Neurodegenerating Brain , 2020, Cells.

[3]  Andreas R. Pfenning,et al.  Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in the aging and Alzheimer human brain , 2018, Nature Neuroscience.

[4]  I. Ferrer,et al.  Role of cellular prion protein in interneuronal amyloid transmission , 2018, Progress in Neurobiology.

[5]  L. Buée,et al.  Potentiating tangle formation reduces acute toxicity of soluble tau species in the rat , 2017, Brain : a journal of neurology.

[6]  J. Hodges,et al.  Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies , 2017, Brain : a journal of neurology.

[7]  F. J. Livesey,et al.  Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways , 2018, Cell reports.

[8]  A. Aguzzi,et al.  The biological function of the cellular prion protein: an update , 2017, BMC Biology.

[9]  A. Consiglio,et al.  iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology , 2017, Molecular Neurobiology.

[10]  R. Wattiez,et al.  Internalization of the Extracellular Full-Length Tau Inside Neuro2A and Cortical Cells Is Enhanced by Phosphorylation , 2016, Biomolecules.

[11]  A. Palmeri,et al.  Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory , 2016, Scientific Reports.

[12]  M. Portero-Otín,et al.  Neuroinflammatory Gene Regulation, Mitochondrial Function, Oxidative Stress, and Brain Lipid Modifications With Disease Progression in Tau P301S Transgenic Mice as a Model of Frontotemporal Lobar Degeneration-Tau , 2015, Journal of neuropathology and experimental neurology.

[13]  J. D. del Río,et al.  Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution , 2014, Molecular Neurobiology.

[14]  G. Perry,et al.  Phosphorylation of tau protein at sites Ser396–404 is one of the earliest events in Alzheimer's disease and Down syndrome , 2014, Neuropathology and applied neurobiology.

[15]  P. Pasqualetti,et al.  Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[16]  F. Wouters,et al.  Impact of the cellular prion protein on amyloid-β and 3PO-tau processing. , 2013, Journal of Alzheimer's disease : JAD.

[17]  J. Yagüe,et al.  PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2 , 2013, Prion.

[18]  F. Albericio,et al.  Neurotoxicity of Prion Peptides Mimicking the Central Domain of the Cellular Prion Protein , 2013, PloS one.

[19]  N. Sahara,et al.  Characteristics of Tau Oligomers , 2013, Front. Neurol..

[20]  S. Love,et al.  Prion Protein Is Decreased in Alzheimer's Brain and Inversely Correlates with BACE1 Activity, Amyloid-β Levels and Braak Stage , 2013, PloS one.

[21]  Sang-Youel Park,et al.  Transcriptional regulation of specific protein 1 (SP1) by hypoxia-inducible factor 1 alpha (HIF-1α) leads to PRNP expression and neuroprotection from toxic prion peptide. , 2012, Biochemical and biophysical research communications.

[22]  C. Zurzolo,et al.  Small Misfolded Tau Species Are Internalized via Bulk Endocytosis and Anterogradely and Retrogradely Transported in Neurons* , 2012, The Journal of Biological Chemistry.

[23]  J. D. del Río,et al.  Unraveling the neuroprotective mechanisms of PrPC in excitotoxicity , 2012, Prion.

[24]  H. Orzechowski,et al.  The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated α-Secretase-mediated Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein* , 2011, The Journal of Biological Chemistry.

[25]  S. Scheff,et al.  Unaltered prion protein expression in Alzheimer disease patients , 2011, Prion.

[26]  P. S. St George-Hyslop,et al.  p53-Dependent Transcriptional Control of Cellular Prion by Presenilins , 2009, The Journal of Neuroscience.

[27]  G. Zamponi.  Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. , 2009 .

[28]  John W. Gilbert,et al.  Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers , 2009, Nature.

[29]  R. Zhao,et al.  ATM-mediated Transcriptional Elevation of Prion in Response to Copper-induced Oxidative Stress* , 2009, Journal of Biological Chemistry.

[30]  C. Masters,et al.  Regulation of Prion Gene Expression by Transcription Factors SP1 and Metal Transcription Factor-1* , 2009, Journal of Biological Chemistry.

[31]  S. Maeda,et al.  Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. , 2008, Current Alzheimer research.

[32]  L. Klomp,et al.  Transcription Factor Sp1 Plays an Important Role in the Regulation of Copper Homeostasis in Mammalian Cells , 2008, Molecular Pharmacology.

[33]  V. Echeverria,et al.  Transcription factor Sp1 dysregulation in Alzheimer's disease , 2008, Journal of neuroscience research.

[34]  F. Jirik,et al.  Prion protein attenuates excitotoxicity by inhibiting NMDA receptors , 2008, The Journal of cell biology.

[35]  B. Elmoualij,et al.  Protective effect of prion protein via the N‐terminal region in mediating a protective effect on paraquat‐induced oxidative injury in neuronal cells , 2008, Journal of neuroscience research.

[36]  Adriano Aguzzi,et al.  Molecular mechanisms of prion pathogenesis. , 2008, Annual review of pathology.

[37]  Bin Zhang,et al.  Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model , 2007, Neuron.

[38]  M. A. Abad,et al.  Neuronal Pentraxin 1 Contributes to the Neuronal Damage Evoked by Amyloid-β and Is Overexpressed in Dystrophic Neurites in Alzheimer's Brain , 2006, The Journal of Neuroscience.

[39]  J. Ávila,et al.  Extracellular tau is toxic to neuronal cells , 2006, FEBS letters.

[40]  S. Rhee,et al.  H2O2, a Necessary Evil for Cell Signaling , 2006, Science.

[41]  B. Puig,et al.  Abnormal Sp1 transcription factor expression in Alzheimer disease and tauopathies , 2006, Neuroscience Letters.

[42]  M. Kao,et al.  Nitric oxide induces prion protein via MEK and p38 MAPK signaling. , 2005, Biochemical and biophysical research communications.

[43]  J. Ávila,et al.  Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments , 2004, Brain Research.

[44]  E. Stadtman,et al.  Ageing and exposure to oxidative stress in vivo differentially affect cellular levels of PrPc in mouse cerebral microvessels and brain parenchyma , 2004, Neuropathology and applied neurobiology.

[45]  Jesus Avila,et al.  Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.

[46]  A. Aguzzi,et al.  Mammalian Prion Biology One Century of Evolving Concepts , 2004, Cell.

[47]  S. Itohara,et al.  Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. , 2003, Biochemical and biophysical research communications.

[48]  N. Vassallo,et al.  Cellular prion protein function in copper homeostasis and redox signalling at the synapse , 2003, Journal of neurochemistry.

[49]  Hirotaka Yoshida,et al.  Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein , 2002, The Journal of Neuroscience.

[50]  W. Klein.  Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets , 2002, Neurochemistry International.

[51]  T. Onodera,et al.  Molecular modulation of expression of prion protein by heat shock , 2002, Molecular Neurobiology.

[52]  I. Izquierdo,et al.  Cellular prion protein: on the road for functions , 2002, FEBS letters.

[53]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[54]  W. Schaffner,et al.  Nucleo-cytoplasmic Trafficking of Metal-regulatory Transcription Factor 1 Is Regulated by Diverse Stress Signals* , 2001, The Journal of Biological Chemistry.

[55]  Kaoru Suzuki,et al.  Negative Regulatory Role of Sp1 in Metal Responsive Element-mediated Transcriptional Activation* , 2001, The Journal of Biological Chemistry.

[56]  J. Collinge,et al.  Isolation and functional characterisation of the promoter region of the human prion protein gene. , 2001, Gene.

[57]  B. Winblad,et al.  The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense , 2001, Neurochemical Research.

[58]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[59]  J. Nichols,et al.  Embryonic stem cells and transgenic mice ubiquitously expressing a tau-tagged green fluorescent protein. , 2000, Developmental biology.

[60]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[61]  S. Reske,et al.  FTDP‐17: An early‐onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation , 1999, Annals of neurology.

[62]  K. Beyreuther,et al.  Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity. , 1999, The American journal of pathology.

[63]  A. Delacourte,et al.  Comparative Biochemistry of Tau in Progressive Supranuclear Palsy, Corticobasal Degeneration, FTDP‐17 and Pick's Disease , 1999, Brain pathology.

[64]  T. Werner,et al.  Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. , 1999, Journal of molecular biology.

[65]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[66]  Inyoul Y. Lee,et al.  Complete genomic sequence and analysis of the prion protein gene region from three mammalian species. , 1998, Genome research.

[67]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Kretzschmar,et al.  Effects of oxidative stress on prion protein expression in pc12 cells , 1997, International Journal of Developmental Neuroscience.

[69]  J. Ávila,et al.  Polymerization of τ into Filaments in the Presence of Heparin: The Minimal Sequence Required for τ ‐ τ Interaction , 1996 .

[70]  I. Grundke‐Iqbal,et al.  Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains , 1994, FEBS letters.

[71]  D. Gottlieb,et al.  FGF and EGF are mitogens for immortalized neural progenitors. , 1994, Journal of neurobiology.

[72]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[73]  J. Ávila,et al.  Overexpression of tau protein in COS-1 cells results in the stabilization of centrosome-independent microtubules and extension of cytoplasmic processes , 1994, Molecular and Cellular Biochemistry.

[74]  I. Grundke‐Iqbal,et al.  Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the Protein , 1992, Journal of neurochemistry.

[75]  L. Hood,et al.  Genomic structure of the human prion protein gene. , 1991, American journal of human genetics.

[76]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[77]  I. Ferrer,et al.  Role of PrPC Expression in Tau Protein Levels and Phosphorylation in Alzheimer’s Disease Evolution , 2014, Molecular Neurobiology.

[78]  N. Hooper,et al.  Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[79]  A. Takashima.  Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy. , 2008, Journal of Alzheimer's disease : JAD.

[80]  N. Inestrosa,et al.  Induction of cellular prion protein gene expression by copper in neurons. , 2006, American journal of physiology. Cell physiology.

[81]  S. Rhee.  Cell signaling. H2O2, a necessary evil for cell signaling. , 2006, Science.

[82]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[83]  H. Braak,et al.  Evolution of Alzheimer's disease related cortical lesions. , 1998, Journal of neural transmission. Supplementum.

[84]  J. Ávila,et al.  Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. , 1996, Journal of neurochemistry.